XPO1 Enables Adaptive Regulation of mRNA Export Required for Genotoxic Stress Tolerance in Cancer CellsRossella Marullo, Leandro Cerchietti, Sarah C. Rutherford et al.|Cancer Research|2023Cited by 26
A Phase I Study of Selinexor and R-ICE in Patients with Relapsed/Refractory Aggressive B-Cell LymphomasSarah C. Rutherford, Peter Martin, John N. Allan et al.|Blood|2020Cited by 8
Adoptive immunotherapy with CB following chemotherapy for patients with refractory myeloid malignancy: chimerism and responseOk-Kyong Chaekal, Koen van Besien, Andromachi Scaradavou et al.|Blood Advances|2020Cited by 5
Adoptive Immunotherapy with Cord Blood for the Treatment of Refractory Acute Myelogenous Leukemia: Feasibility, Safety, and Preliminary OutcomesUsama Gergis, Koen van Besien, Adrienne A. Phillips et al.|Transplantation and Cellular Therapy|2018Cited by 4
Does Presence of Persistent Molecular Mutations Matter in AML Patients Undergoing Allogeneic Stem Cell Transplant?Jingmei Hsu, Koen van Besien, Sang‐Min Lee et al.|Transplantation and Cellular Therapy|2019Cited by 3